449 related articles for article (PubMed ID: 25800544)
1. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.
Mikolajczak SA; Vaughan AM; Kangwanrangsan N; Roobsoong W; Fishbaugher M; Yimamnuaychok N; Rezakhani N; Lakshmanan V; Singh N; Kaushansky A; Camargo N; Baldwin M; Lindner SE; Adams JH; Sattabongkot J; Kappe SH
Cell Host Microbe; 2015 Apr; 17(4):526-35. PubMed ID: 25800544
[TBL] [Abstract][Full Text] [Related]
2. Mass Spectrometry Identification of Biomarkers in Extracellular Vesicles From Plasmodium vivax Liver Hypnozoite Infections.
Gualdrón-López M; Díaz-Varela M; Zanghi G; Aparici-Herraiz I; Steel RWJ; Schäfer C; Cuscó P; Chuenchob V; Kangwangransan N; Billman ZP; Olsen TM; González JR; Roobsoong W; Sattabongkot J; Murphy SC; Mikolajczak SA; Borràs E; Sabidó E; Fernandez-Becerra C; Flannery EL; Kappe SHI; Del Portillo HA
Mol Cell Proteomics; 2022 Oct; 21(10):100406. PubMed ID: 36030044
[TBL] [Abstract][Full Text] [Related]
3.
Schäfer C; Zanghi G; Vaughan AM; Kappe SHI
Annu Rev Microbiol; 2021 Oct; 75():87-106. PubMed ID: 34196569
[No Abstract] [Full Text] [Related]
4. Plasmodium vivax pre-erythrocytic stages and the latent hypnozoite.
Zanghi G; Vaughan AM
Parasitol Int; 2021 Dec; 85():102447. PubMed ID: 34474178
[TBL] [Abstract][Full Text] [Related]
5.
Flannery EL; Kangwanrangsan N; Chuenchob V; Roobsoong W; Fishbaugher M; Zhou K; Billman ZP; Martinson T; Olsen TM; Schäfer C; Campo B; Murphy SC; Mikolajczak SA; Kappe SHI; Sattabongkot J
Mol Ther Methods Clin Dev; 2022 Sep; 26():427-440. PubMed ID: 36092359
[No Abstract] [Full Text] [Related]
6. A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.
Roth A; Maher SP; Conway AJ; Ubalee R; Chaumeau V; Andolina C; Kaba SA; Vantaux A; Bakowski MA; Thomson-Luque R; Adapa SR; Singh N; Barnes SJ; Cooper CA; Rouillier M; McNamara CW; Mikolajczak SA; Sather N; Witkowski B; Campo B; Kappe SHI; Lanar DE; Nosten F; Davidson S; Jiang RHY; Kyle DE; Adams JH
Nat Commun; 2018 May; 9(1):1837. PubMed ID: 29743474
[TBL] [Abstract][Full Text] [Related]
7. Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo.
Adekunle AI; Pinkevych M; McGready R; Luxemburger C; White LJ; Nosten F; Cromer D; Davenport MP
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003595. PubMed ID: 25780913
[TBL] [Abstract][Full Text] [Related]
8. Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission.
White MT; Karl S; Battle KE; Hay SI; Mueller I; Ghani AC
Elife; 2014 Nov; 3():. PubMed ID: 25406065
[TBL] [Abstract][Full Text] [Related]
9. Partial protection against P. vivax infection diminishes hypnozoite burden and blood-stage relapses.
Schäfer C; Dambrauskas N; Reynolds LM; Trakhimets O; Raappana A; Flannery EL; Roobsoong W; Sattabongkot J; Mikolajczak SA; Kappe SHI; Sather DN
Cell Host Microbe; 2021 May; 29(5):752-756.e4. PubMed ID: 33857426
[TBL] [Abstract][Full Text] [Related]
10. Azithromycin disrupts apicoplast biogenesis in replicating and dormant liver stages of the relapsing malaria parasites Plasmodium vivax and Plasmodium cynomolgi.
Amanzougaghene N; Tajeri S; Franetich JF; Ashraf K; Soulard V; Bigeard P; Guindo CO; Bouillier C; Lemaitre J; Relouzat F; Legrand R; Kocken CHM; Zeeman AM; Roobsoong W; Sattabongkot J; Yang Z; Snounou G; Mazier D
Int J Antimicrob Agents; 2024 May; 63(5):107112. PubMed ID: 38367843
[TBL] [Abstract][Full Text] [Related]
11. Imported tertian malaria resistant to primaquine.
Na DJ; Han JD; Cha DY; Song IK; Choi HW; Chung EA; Park CW; Choi JS
Korean J Intern Med; 1999 Jul; 14(2):86-9. PubMed ID: 10461431
[TBL] [Abstract][Full Text] [Related]
12. Characterization of
Gualdrón-López M; Flannery EL; Kangwanrangsan N; Chuenchob V; Fernandez-Orth D; Segui-Barber J; Royo F; Falcón-Pérez JM; Fernandez-Becerra C; Lacerda MVG; Kappe SHI; Sattabongkot J; Gonzalez JR; Mikolajczak SA; Del Portillo HA
Front Microbiol; 2018; 9():1271. PubMed ID: 29988527
[TBL] [Abstract][Full Text] [Related]
13. [Two imported and relapsed of Plasmodium vivax malaria cases and primaquine prophylaxis].
Hatipoğlu M; Ulçay A; Turhan V; Karagöz E; Erdem H; Acar A; Oncül O; Görenek L
Turkiye Parazitol Derg; 2014 Jun; 38(2):120-3. PubMed ID: 25016120
[TBL] [Abstract][Full Text] [Related]
14. A novel immortalized hepatocyte-like cell line (imHC) supports in vitro liver stage development of the human malarial parasite Plasmodium vivax.
Pewkliang Y; Rungin S; Lerdpanyangam K; Duangmanee A; Kanjanasirirat P; Suthivanich P; Sa-Ngiamsuntorn K; Borwornpinyo S; Sattabongkot J; Patrapuvich R; Hongeng S
Malar J; 2018 Jan; 17(1):50. PubMed ID: 29370800
[TBL] [Abstract][Full Text] [Related]
15. Recurrent Plasmodium vivax malaria due to dose-dependent primaquine resistance: a case report.
Kristensen KL; Dragsted UB
Scand J Infect Dis; 2014 Jan; 46(1):63-5. PubMed ID: 23957539
[TBL] [Abstract][Full Text] [Related]
16. Biological concepts in recurrent Plasmodium vivax malaria.
Markus MB
Parasitology; 2018 Nov; 145(13):1765-1771. PubMed ID: 29564998
[TBL] [Abstract][Full Text] [Related]
17. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
[TBL] [Abstract][Full Text] [Related]
18. Hypnozoite dynamics for Plasmodium vivax malaria: The epidemiological effects of radical cure.
Mehra S; Stadler E; Khoury D; McCaw JM; Flegg JA
J Theor Biol; 2022 Mar; 537():111014. PubMed ID: 35016895
[TBL] [Abstract][Full Text] [Related]
19. Primaquine for Plasmodium vivax radical cure: What we do not know and why it matters.
Popovici J; Tebben K; Witkowski B; Serre D
Int J Parasitol Drugs Drug Resist; 2021 Apr; 15():36-42. PubMed ID: 33529838
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium vivax liver stage assay platforms using Indian clinical isolates.
Subramani PA; Vartak-Sharma N; Sreekumar S; Mathur P; Nayer B; Dakhore S; Basavanna SK; Kalappa DM; Krishnamurthy RV; Mukhi B; Mishra P; Yoshida N; Ghosh SK; Shandil R; Narayanan S; Campo B; Hasegawa K; Anvikar AR; Valecha N; Sundaramurthy V
Malar J; 2020 Jun; 19(1):214. PubMed ID: 32571333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
